XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2023   46,078,464      
Beginning balance at Dec. 31, 2023 $ 1,892,998 $ 461 $ 472,201 $ 1,491,956 $ (71,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 10,627     10,627  
Other comprehensive income (loss), net of tax expense (benefit) (6,593)       (6,593)
Issuance of restricted stock, net (in shares)   56,244      
Issuance of restricted stock, net (3,923)   (5,152) 1,229  
Share-based compensation 8,872   8,872    
Other, net 31   5 26  
Ending balance (in shares) at Mar. 31, 2024   46,134,708      
Ending balance at Mar. 31, 2024 $ 1,902,012 $ 461 475,926 1,503,838 (78,213)
Beginning balance (in shares) at Dec. 31, 2024 42,848,339 42,848,339      
Beginning balance at Dec. 31, 2024 $ 1,810,882 $ 428 491,891 1,401,034 (82,471)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 24,239     24,239  
Other comprehensive income (loss), net of tax expense (benefit) 11,691       11,691
Issuance of restricted stock, net (in shares)   132,395      
Issuance of restricted stock, net (4,303) $ 1 (7,832) 3,528  
Repurchase and retirement of common stock (in shares)   (750,000)      
Repurchase and retirement of common stock (30,903) $ (7) (8,693) (22,203)  
Share-based compensation 9,751   9,751    
Other, net $ 8   (109) 117  
Ending balance (in shares) at Mar. 31, 2025 42,230,734 42,230,734      
Ending balance at Mar. 31, 2025 $ 1,821,365 $ 422 $ 485,008 $ 1,406,715 $ (70,780)